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IMPACT OF GAIN-OF-FUNCTION MUTATIONS IN THE LOW DENSITY LIPOPROTEIN
RECEPTOR RELATED PROTEIN 5 (LRP5) ON GLUCOSE AND LIPID HOMEOSTASIS. Dinah Foer,
Meiling Zhu, Christine Simpson, Grace Lee, Rebecca Sullivan, and Karl L. Insogna. Section of
Endocrinology, Department of Internal Medicine, Yale University, School of Medicine, New Haven, CT.
Investigations in animal models suggest a physiologic link between LRP5 and glucose and lipid
homeostasis. However, the data in human studies is far from consensus. While LRP5 has been shown to be
critical to Wnt signaling, the molecular mechanism for the effect on metabolism is unknown. We
hypothesize that a high bone mass (HBM) mutation in LRP5 will lead to improved glucose and lipid
homeostasis. We aim to measure the impact of these mutated receptors on human glucose and lipid
metabolism and to investigate the pathway(s) by which Wnt may affect glucose metabolism in vitro.
Eleven subjects with HBM-causing LRP5 mutations were matched by gender, age, and body mass index
(BMI) to 22 unrelated control subjects. Hemoglobin A1c (HbA1c), estimated average glucose (eAG),
HOMA-B, HOMA-IR, and lipid panel were analyzed. An oral glucose tolerance test and 1HMRS study of
liver and skeletal muscle were performed on a subset of affected patients. Primary hepatocytes and HepG2
cells were treated in vitro with Wnt3a, and PEPCK-C mRNA expression was measured by QPCR. INS-1
cells and human pancreatic islet beta-cells were assayed for glucose-stimulated insulin secretion using an
ELISA technique. Statistical differences were analyzed using the unpaired Student t-test and one-way
ANOVA. There were no statistically significant differences between affected and control populations for
HbA1c, eAG, insulin, HOMA-B and HOMA-IR. Differences in total cholesterol, triglycerides, and HDL,
were not significant. However, LDL levels were significantly lower in affected subjects (p=0.04). Wnt did
not effect PEPCK-C expression. Wnt did not significantly effect glucose-stimulated insulin secretion in
INS-1 cells and human islets. In summary, this is the first investigation on the metabolic consequences of
LRP5 mutations in human kindreds with HBM-causing mutations. Our data does not support the hypothesis
that LRP5 improves glucose metabolism in these individuals. The data does suggest that there may be a
specific, beneficial effect of LRP5 on LDL cholesterol, however additional studies need to be done to
confirm the effect and elucidate the mechanism.
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INTRODUCTION)
!
The!low)density!lipoprotein!related!protein!5!(LRP5)!came!to!clinical!attention!in!
2001!when!Gong!and!coworkers!reported!that!loss!of!function!mutations!in!this!
receptor!caused!profound!osteoporosis!and!fractures!(Gong!et!al.,!2001).!In!2002,!
Yale!University!investigators!reported!that!a!mutation!in!LRP5!that!conferred!
resistance!to!endogenous!inhibitors!such!as!Dkk1,!caused!another!dramatic!skeletal!
phenotype.!A!kindred!was!identified!with!an!inherited!syndrome!of!high!bone!mass!
that!was!phenotypically!characterized!by!a!reduced!angle!of!the!jaw,!torus!palatinus,!
and!extremely!high!bone!density!when!measured!by!dual!energy!x)ray!
absorptiometry!(Boyden!et!al.,!2002).!The!syndrome!was!inherited!in!an!autosomal!
dominant!pattern.!Interestingly,!members!of!the!kindred!reported!difficulty!staying!
afloat!while!swimming.!Affected!family!members!were!shown!to!have!a!single!base!
pair!mutation!causing!a!glycine!to!valine!change!at!position!171.!Glycine!171!is!
evolutionarily!conserved!in!LRP5!and!in!its!homologues,!indicating!a!critical!role!for!
this!residue!(Hey!et!al.,!1998).!Subsequently!additional!high!bone!mass!(HBM))
causing!mutations!in!LRP5!have!been!identified!in!other!kindreds!(Van!Wesenbeeck!
et!al.,!2003;!Whyte,!Reinus,!&!Mumm,!2004).!The!exact!mechanism!by!which!these!
high!bone!mass!causing!mutations!lead!to!the!phenotype!described!is!not!
completely!understood.!However!as!noted,!the!LRP5!G171V!mutation!is!resistant!to!
the!actions!of!the!endogenous!inhibitor!Dickopf!1!(Dkk1).!Thus,!while!the!receptor!
does!not!signal!in!the!absence!of!ligand!and!appears!to!signal!normally!in!the!
presence!of!ligand,!when!Dkk1!is!added!ligand)dependent!signaling!is!largely!
unaffected!(Boyden!et!al.,!2002).!
!

!

!
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The!role!of!LRP5!skeletal!homeostasis!is!now!well!established!(Williams!&!Insogna,!
2009).!More!recently,!animal!models!with!both!HBM!and!low!bone!mass!(LBM))
causing!mutations,!as!well!as!human!studies!in!populations!with!LBM)causing!
mutations,!implicate!a!role!for!LRP5!in!glucose!metabolism!and!lipid!homeostasis!
(Fujino!et!al.,!2003;!Saarinen!et!al.,!2010).!This!introduction!will!review!LRP5’s!
function!and!its!key!signaling!pathways,!providing!a!background!for!understanding!
the!potential!role!of!LRP5!in!human!metabolism.!!
!
LRP5.&The!LRP5!gene!is!located!on!chromosome!11q13.4.!The!encoded!protein!in!
vertebrates!is!a!single!pass!transmembrane!molecule!that!is!a!receptor!for!low)
density)lipoprotein!(LDL)!(Galora!et!al.,!2013).!The!protein!also!serves!as!a!co)
receptor,!along!with!its!homologue!LRP6!and!the!family!of!Frizzled!transmembrane!
receptors,!for!the!wingless)type!MMTV!integration!site!family!of!glycoproteins,!
commonly!denoted!as!Wnt!proteins.!The!Wnt!genes,!of!which!there!are!currently!
nineteen,!encode!secreted!glycoproteins,!generating!signal!transduction!cascades!
that!are!critical!to!nearly!every!event!during!development!(Moon,!2005).!Wnt!
signaling!persists!postnatally!to!regulate!expression!of!specific!target!genes!in!self)
renewing!adult!tissues!such!as!gut,!hair!follicle,!bone,!and!the!hematopoietic!system.!
Mutations!in!Wnt!signaling!have!subsequently!been!identified!in!oncogenesis,!
notably!in!colon!cancer!and!liquid!cancers!(Reya!&!Clevers,!2005),!and!is!an!active!
area!of!cancer!research.!!
&
&
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Wnt&signaling&pathways.&&Three!pathways!are!activated!following!Wnt!receptor!
engagement:!the!canonical!Wnt!pathway,!the!non)canonical!planar!cell!polarity!
pathway!(PCP),!and!the!Wnt/Ca2+!pathway.!The!canonical!pathway!is!the!best!
studied!of!these!(Clevers,!2006).!In!this!pathway,!Wnt!ligands!bind!to!a!Frizzled/LRP!
complex,!interacting!with!Dash!and!Axin!proteins,!and!preventing!the!proteosomal!
degradation!of!beta)catenin,!which!plays!a!major!role!in!the!canonical!pathway.!As!
just!noted,!in!the!absence!of!Wnt!signaling,!beta)catenin!is!targeted!for!
phosphorylation)dependent!destruction.!Stabilized!and!unphosphorylated,!beta5
catenin!accumulates!in!the!cytoplasm!and!translocates!to!the!nucleus!where!it!binds!
transcription!factors!and!transcriptionally!activates!a!wide!range!of!target!genes!
(Tamai!et!al.,!2004).!Secreted!Dkk!proteins!inhibit!Wnt!signaling!by!direct!binding!to!
LRP5/6,!promoting!internalization!and!inactivation!of!the!receptors!(Tamai!et!al.,!
2000).!&
&
Bone.&&The!role!of!LRP5!in!bone!accrual!is!well)established.!In!osteoblasts!LRP5!
transduces!Wnt!signaling!via!the!canonical!pathway.!LRP5)deficient!mice!
demonstrate!low!bone!mass!as!a!result!of!impaired!bone!formation!attributable!to!
defects!in!osteoblast!proliferation!and!maturation!(Kato!et!al.,!2002).!Of!note,!LRP5)
deficient!mice!also!demonstrate!persistent!embryonic!eye!vascularization!as!a!result!
of!failed!macrophage)!mediated!apoptosis.!Conversely,!transgenic!mice!expressing!a!
gain)of)function!LRP5!allele!in!osteoblasts!have!increased!bone!density!and!
increased!osteoblast!activity!(Babij!et!al.,!2003).!&
!

!
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As!noted,!humans!homozygous!for!loss)of)function!mutations!in!LRP5!are!consistent!
with!observations!in!animal!models.!These!individuals!have!an!autosomal!recessive!
disorder,!Osteoporosis!Pseudoglioma!(OPPG)!syndrome,!characterized!by!severe!
osteoporosis,!childhood!fractures!and!blindness!due!to!abnormal!vitreous!
development!(Gong!et!al.,!2001).!Common!polymorphic!variants!in!LRP5!in!a!variety!
of!human!ethnic!populations!and!age!groups!have!been!shown!to!influence!bone!
density!in!the!general!population,!indicating!that!in!addition!to!its!role!in!the!rare!
inherited!syndromes!just!described,!it!has!an!important!role!in!regulating!normal!
skeletal!metabolism!(Jiang!et!al.,!2010;!Saarinen!et!al.,!2010;!Zenibayashi!et!al.,!
2008).!
)
Consistent!with!a!critical!role!of!Wnt!signaling!in!bone!homeostasis!are!the!skeletal!
phenotypes!observed!with!loss!of!function!mutations!in!the!endogenous!inhibitors!
of!Wnt!signaling!Dkk1!(described!above)!and!sclerostin.!Heterozygous!loss!of!
function!mutations!in!Dkk1!lead!to!high!bone!mass!in!mice!(Morvan!et!al.,!2006).!In!
humans,!loss)of)function!mutations!in!sclerostin!lead!to!a!condition!called!
sclerosteosis,!characterized!by!massive!and!progressive!increases!in!bone!mass!
resulting!ultimately!in!nerve!entrapment!(Li!et!al.,!2005;!Semenov,!Tamai,!&!He,!
2005).!!
!
Lipid&Homeostasis.&&Animal!models!of!LRP5!deficiency!demonstrate!impaired!lipid!
homeostasis!under!certain!experimental!conditions.!LRP5!deficient!mice!fed!a!high!
fat!diet!developed!high!plasma!cholesterol!levels,!marked!by!impaired!hepatic!

!

!

!
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clearance!of!chylomicron!remnants.!When!fed!a!normal!diet,!these!mice!had!normal!
plasma!lipid!levels!(Fujino!et!al.,!2003).!However,!mice!deficient!in!both!ApoE!and!
LRP5!fed!a!normal!diet!exhibited!approximately!60%!higher!plasma!cholesterol!
levels!compared!with!ApoE!knockout!mice.!Analysis!of!lipid!components!showed!
that!plasma!clearance!of!diet)derived!triglycerides!was!severely!impaired!by!LRP5!
but!not!ApoE!deficiency.!These!data!suggest!that!in!a!murine!model,!LRP5!mediates!
catabolism!of!plasma!lipoproteins!through!ApoE!dependent!and!independent!
mechanisms!(Magoori!et!al.,!2003).!&
!
In!human!studies,!an!impact!of!LRP5!on!lipid!metabolism!is!less!well!established.!
Two!single!nucleotide!polymorphisms!in!LRP5!have!been!associated!with!a!higher!
risk!for!of!abdominal!aortic!aneurysm.!Specifically,!these!polymorphisms!result!in!
reduced!expression!of!LRP5!causing!impaired!clearance!of!lipoprotein!(a),!an!
atherothrombotic!risk!factor!(Giusti!et!al.,!2009).!A!study!of!a!Chinese!Han!
population!found!an!association!between!two!single!nucleotide!polymorphisms!in!
LRP5!and!increased!circulating!levels!of!total!cholesterol!(Jiang!et!al.,!2010).!In!a!
prepubertal!Finnish!population,!variants!in!LRP5!were!associated!with!higher!total!
and!LDL!cholesterol!levels!(Lappalainen!et!al.,!2009).!However,!in!contrast,!a!study!
of!13!Finnish!individuals!from!one!family!with!three!different!LBM)causing!LRP5!
mutations!did!not!demonstrate!hypercholesterolemia!or!elevated!triglyceride!levels!
(Saarinen!et!al.,!2010).!
!
The!findings!of!abnormal!lipid!metabolism!in!murine!models!of!LRP5!deficiency!and!

!

!

!

6!

in!some!human!studies,!in!combination!with!the!role!of!LRP5!in!osteoporosis,!have!
prompted!investigation!of!LRP5!as!a!candidate!gene!underlying!the!metabolic!
syndrome.!Findings!from!one!study!in!a!Caucasian!population!suggested!an!
association!of!SNPs!and!haplotypes!in!the!LRP5!gene,!with!obesity,!although!the!
molecular!mechanism!was!not!defined!(Guo!et!al.,!2006).!In!contrast,!a!study!in!a!
Japanese!population,!which!included!the!same!SNP,!did!not!find!an!association!
between!body!mass!index!(BMI)!and!that!same!polymorphism!or!haplotypes!
comprising!it.!Furthermore,!other!studies!have!found!no!evidence!of!an!association!
between!LRP5!polymorphisms!and!BMI,!homeostatic!model!assessment!of!
estimated!beta)cell!function!(HOMA)B),!estimated!insulin!resistance!(HOMA)IR),!or!
serum!lipids!in!diabetic!versus!non)diabetic!controls!(Zenibayashi!et!al.,!2008).!
Consistent!with!this,!Jing!et!al!(mentioned!above)!found!no!association!of!LRP5!
polymorphisms!with!BMI!(Jiang!et!al.,!2010).!!
)
Glucose&metabolism.!A!potential!role!for!LRP5!in!glucose!metabolism!was!first!
reported!in!an!animal!model.!LRP5)deficient!mice,!fed!a!normal!diet,!were!found!to!
have!impaired!glucose!tolerance!and!blunted!glucose)induced!insulin!secretion!by!
isolated!pancreatic!beta!cells.!Islets!isolated!from!these!mice!had!reduced!
intracellular!levels!ATP!and!Ca2+,!and!decreased!mRNA!levels!of!insulin!signaling!
targets!including!glucokinase!and!HNF4!under!stimulatory!conditions.!Wnt3a!failed!
to!induce!insulin!secretion!in!LRP5)deficient!islets,!while!in!wild!type!islets!both!
Wnt3a!and!Wnt!5a!stimulated!glucose)induced!insulin!secretion!(Fujino!et!al.,!
2003).!&

!

!
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The!suggested!link!between!LRP5!and!glucose!metabolism!prompted!a!range!of!
human!studies.!However,!findings!to!date!have!been!less!definitive!than!those!in!
animal!models.!No!statistically!significant!associations!have!been!found!between!
genetic!polymorphisms!in!LRP5!and!glucose!metabolism,!as!assessed!by!
Hemoglobin!A1c!(HbA1c)!(Jiang!et!al.,!2010),!HOMA)B,!or!HOMA)IR,!was!found!in!
individuals!with!type!2!diabetes!or!in!non)diabetic!subjects!(Lappalainen!et!al.,!
2009;!Zenibayashi!et!al.,!2008).!However,!the!single!nucleotide!polymorphisms!that!
give!rise!to!the!HBM!phenotypes!have!never!been!included!in!any!of!these!analyses!
for!the!obvious!reason!that!their!frequency!in!the!general!population!is!exceedingly!
rare.!A!study!of!Finnish!individuals!who!were!homozygous,!compound!
heterozygous,!or!heterozygous!for!three!different!deletional!LBM)causing!LRP5!
mutations,!found!that!approximately!50%!of!these!subjects!had!diabetes,!with!
abnormalities!reported!in!either!blood!HbA1c!levels!or!in!oral!glucose!tolerance!
tests!(OGTT)!(Saarinen!et!al.,!2010).!Those!with!abnormal!OGTTs!had!low!first!
phase!insulin!release!but!were!not!insulin!resistant.!These!interesting!observations!
are!limited!by!the!lack!of!a!control!population.!For!example,!this!population!included!
overweight!patients!as!well!as!patients!with!significant!comorbidities,!that!could!
have!confounded!the!result.!The!study!also!lacked!statistical!power!to!detect!
potential!differences!in!metabolic!parameters.!
&
LRP6.&While!this!thesis!focuses!on!LRP5!and!its!role!in!human!metabolism,!recent!
studies!have!elucidated!a!role!for!LRP6!in!fuel!metabolism.!Mani!et!al.!identified!a!
non)conservative!loss!of!function!mutation!in!LRP6!that!attenuates!transcription!

!

!
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factor!7!like)2!(TCF7L2))dependent!transcription!of!the!insulin!receptor!gene!(Singh!
et!al.,!2013).!Affected!individuals!have!a!syndrome!of!early)onset!type!2!diabetes,!
coronary!artery!disease,!metabolic!syndrome,!and!osteoporosis!inherited!in!an!
autosomal!dominant!pattern.!Carriers!exhibit!hyperinsulinemia!and!reduced!insulin!
sensitivity!in!peripheral!tissues,!particularly!skeletal!muscle,!which!can!be!detected!
prior!to!the!development!of!impaired!glucose!tolerance!(Mani!et!al.,!2007).!
&
STATEMENT)OF)PURPOSE,)HYPOTHESIS,)SPECIFIC)AIMS)OF)THESIS)
As!reviewed!in!the!Introduction,!studies!in!animals!suggest!a!physiologic!link!
between!LRP5!and!metabolism.!However,!there!is!no!consensus!opinion!in!human!
studies.!In!addition!there!have!been!no!human!studies!on!the!metabolic!
consequences!of!HBM)causing!LRP5!mutations.!This!thesis!explores!the!role!of!LRP5!
in!human!glucose!and!lipid!metabolism!by!studying!volunteers!with!HBM)causing!
LRP5!mutations.!Studies!in!this!population!could!provide!insights!into!LRP5’s!role,!if!
any,!in!common!diseases!such!as!diabetes!and!hypercholesterolemia.!
!
We!hypothesize!that!the!LRP5!pathway!has!a!similar!role!in!humans,!as!in!mice,!and!
that!HBM)causing!LRP5!mutations!in!humans!will!lead!to!improved!glucose!
homeostasis!and!lipid!metabolism!compared!to!matched!controls.!The!specific!aims!
of!this!thesis!are!to:!
1.!Measure!the!impact!of!HBM)causing!mutations!in!LRP5!on!human!glucose!and!
lipid!metabolism!
2.!Investigate!the!pathway(s)!by!which!Wnt!may!affect!glucose!metabolism!in&vitro!
!

!

!
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METHODS)
Study&Subjects.)Nine!subjects!with!the!G171V!HBM)causing!LRP5!mutation!were!
recruited!from!two!previously!reported!kindreds!(Fig.1A,!Fig.1B)!(Boyden!et!al.,!
2002;!Lee!et!al.,!2013).!Two!subjects!with!an!N198S!(asparagine!to!serine)!mutation!
in!LRP5!associated!with!HBM!were!also!studied!(Lee!et!al.,!2013).!We!also!recruited!
22!gender,!age,!race,!and!body!mass!index!(BMI))matched!individuals!unrelated!to!
the!kindred!members!to!serve!as!controls.!
!
HbA1c!and!insulin!were!measured!in!all!participants.!Two!control!subjects!matched!
for!gender,!age,!and!BMI!were!recruited!for!every!study!subject.!Five!subjects,!in!
total,!from!the!affected!and!control!groups!reported!taking!lipid!lowering!
medications!and!were!excluded!from!the!lipid!analysis!portion!of!the!study.!Recent!
data!suggest!a!link!between!HMG)CoA!reductase!inhibitor!use!and!type!2!diabetes!
(Carter!et!al.,!2013).!As!this!association!has!not!established!causality,!we!chose!not!
to!exclude!these!five!subjects!from!the!glucose!analysis.!Three!subjects!agreed!to!
undergo!an!OGTT,!and!two!underwent!MRS!studies.!These!subjects!were!matched!
for!age,!race,!BMI,!and!activity!level!to!a!large!control!group!(N=54).!
!
The!study!complied!with!the!World!Medical!Association!Declaration!of!Helsinki!–!
Ethical!Principles!for!Medical!Research!Involving!Human!Subjects.!The!study!was!
approved!by!the!Yale!Human!Research!Protection!Program!IRB.!All!subjects!gave!
written!consent!to!participate!in!the!study!after!the!purpose,!nature!and!potential!
risks!of!the!studies!were!explained.!

!
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I)Human)Studies)
The!author!of!this!thesis!recruited,!enrolled!and!studied!all!volunteers!whose!data!
are!reported!here!unless!otherwise!specified.!
!
Hemoglobin&A1c.!Participants!were!instructed!to!fast!from!midnight!onward.!All!
blood!sampling!took!place!between!7am)10am!on!the!Yale!New!Haven!Hospital!
Research!Unit.!HbA1c!was!measured!in!whole!blood!by!the!Yale!New!Haven!Clinical!
Immunology!Lab,!using!Premier!Hb9210!boronate!affinity!high)performance!liquid!
chromatography!with!eluates!measured!at!413±2nM!absorbance!according!to!
manufacturers!instructions!(Trinity!Biotech;!Jamestown,!NY).!!
!
Insulin.!Plasma!concentrations!of!insulin!were!measured!with!a!Human!Insulin!
Specific!RIA!Kit!(Millipore;!St.!Charles,!MO)!in!the!Yale!Mineral!Metabolism!
Laboratory.!HOMA)B!and!HOMA)IR!were!mathematically!derived!from!the!
measured!insulin!value!and!the!estimated!average!glucose!(eAG)!from!the!same!
blood!sample!(Nathan!et!al.,!2008).!!
!
OGTT.!!Whole!body!insulin!sensitivity!was!assessed!in!collaboration!with!Dr.!Kitt!
Falk!Petersen!(Yale!University,!Department!of!Internal!Medicine,!Section!of!
Endocrinology;!New!Haven,!CT)!with!a!3)hr!OGTT.!Subjects!were!fasted!from!8pm!
the!night!prior!to!testing.!Twenty!minutes!after!insertion!of!an!antecubital!IV!line,!
fasting!blood!samples!were!collected!for!determination!of!plasma!glucose.!The!75g!
dextrose!drink!(Glucola;!Curtin!Matheson!Scientific,!Houston,!Tx)!was!then!

!
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administered,!and!blood!samples!collected!at!10,!20,!30,!60,!90,!120,!150,!and!180!
min!for!determination!of!plasma!glucose!and!insulin!concentrations.!The!Insulin!
Sensitivity!Index!(ISI)!was!used!to!estimate!insulin!sensitivity!(Petersen!et!al.,!
2006).!Plasma!glucose!concentrations!during!the!OGTT!were!measured!using!a!YSI!
STAT!2700!Analyzer!(Yellow!Springs!Instrument!Co.,!Yellow!Springs,!CA).!Insulin!
concentrations!were!measured!using!a!Linco!RIA!kit!(EMD!Millipore;!Billerica,!
Massachusetts).!
!
Lipid&panel.!!Total!cholesterol,!high!density!lipoprotein!(HDL),!and!triglycerides!(TG)!
concentrations!were!measured!on!an!Ace!Clinical!Chemistry!System!autoanalyzer!
(Alfa!Wassermann;!West!Caldwell,!NJ).!Low!density!lipoprotein!(LDL)!
concentrations!were!calculated!from!TC,!HDL,!and!TG!with!the!Friedewald!formula!
(Friedewald,!Levy,!&!Fredrickson,!1972).!!
!
1H&MRS&Assessment&of&Intramyocellular,&Extramyocellular,&and&Hepatic&Lipid&Content.&&

Intramyocellular!(IMCL)!and!extramyocellular!(EMCL)!and!hepatic!lipid!contents!
1

were!measured!using! H!MRS!also!in!collaboration!with!Dr.!Kitt!Falk!Petersen!as!
previously!described!(Petersen!et!al.,!2006).!Muscle!lipid!content!was!measured!in!
the!soleus!muscle!using!an!8.5!cm!diameter!circular!13C!surface!coil!with!twin,!
orthogonal!circular!13)cm!1H!quadrature!coils.!The!probe!was!tuned!and!matched!
and!scout!images!of!the!lower!leg!were!obtained!to!ensure!correct!positioning!of!the!
subject!and!to!define!an!adequate!volume!for!localized!shimming!using!the!
FASTMAP!procedure!(Gruetter,!1993).!The!liver!TG!content!was!measure!by!1H!

!
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respiratory)gated!STEAM!spectroscopy!in!a!15x15x15!mm3!voxel.!Acquisition!was!
synchronized!to!the!respiratory!cycle!and!triggered!at!the!end!of!expiration.!A!
water)suppressed!lipid!spectrum!and!a!lipid)suppressed!water!spectrum!were!
acquired!in!three!different!locations!of!the!liver!to!account!for!liver!inhomogeneity.!
A!minimum!of!six!spectra!was!acquired!for!each!subject!and!the!total!lipid!content!
was!averaged!and!calculated.!In!addition,!hepatic!lipid!content!was!corrected!for!
transverse!relaxation,!using!the!transverse!relaxation!times!of!22!ms!for!water!and!
44!ms!for!lipid,!as!previously!described!(Rabol,!Petersen,!Dufour,!Flannery,!&!
Shulman,!2011).!&
&
II)In#vitro)studies))
The!author!of!this!thesis!designed!and!conducted!all!the!in&vitro!experiments!
described!here,!unless!otherwise!specified.!
!
Materials.!!Recombinant!murine!Wnt3a!and!human!Wnt3a!were!purchased!from!
R&D!Systems!(Minneapolis,!MN).!References!to!“Wnt”!in!these!experiments!will!only!
refer!to!Wnt3a!use.!Insulin!Humalog!ND1048!was!from!Eli!Lilly!and!Company!
(Indianapolis,!IN).!Glucagon!and!dexamethasone!were!purchased!from!Sigma)
Aldrich!(St.!Louis,!MO).!DMEM,!heat)inactivated!fetal!bovine!serum!(FBS),!and!Opti)
MEM!GlutaMAX!were!all!purchased!from!Gibco)Life!Technologies!(Carlsbad,!CA).!!All!
reagents!used!for!INS)1!cell!cultures!were!purchased!from!Sigma)Aldrich!(St.!Louis,!
MO)!unless!otherwise!specified.!
!
!
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Cells.!!Primary!hepatocytes!isolated!from!Sprague!Dawley!(SD)!rats!were!purchased!
from!Life!Technologies!(Carlsbad,!CA).!HepG2!cells!(p76)!were!purchased!from!
American!Type!Culture!Collection!(ATCC;!Manassas,!VA).!Expression!levels!of!LRP5!
transcripts!were!measured!in!tissues!isolated!from!SD!rat!purchased!from!Charles!
River!(Wilmington,!MA).!The!INS)1!832/13!rat!insulinoma!cell!line!was!generously!
provided!by!Dr.!Richard!Kibbey!(Yale!University;!New!Haven,!CT),!and!initial!stocks!
were!originally!received!from!Christopher!Newgard!(Duke!University;!Durham,!
North!Carolina)!(Hohmeier!et!al.,!2000).!!
!
Primary&Rat&Islets.!!Sprague!Dawley!rat!pancreatic!islets!were!prepared!by!Tamara!
Dlugos!in!the!Yale!Diabetes!Endocrinology!Research!Center.!!
!
Primary&Hepatocyte&Cell&Cultures.!!Pelleted!cells!were!re)suspended!twice!in!media!
containing!high!glucose!DMEM,!10%!FBS,!1nM!dexamethasone,!1nM!insulin,!and!
P/S!(1:100).!Cells!were!plated!at!an!initial!density!of!5x105!in!collagen)coated!6)well!
plates!and!incubated!for!four!hours!at!37°C.!Cells!were!then!washed!1x!with!
phosphate!buffered!saline!(PBS)!and!incubated!at!37°C!overnight!in!OptiMEM)
GlutaMAX.!The!next!morning!cells!were!washed!1x!with!PBS!and!incubated!for!two!
hours!in!glucose)free!DMEM!containing!sodium!bicarbonate.!Cells!were!washed!
again!with!PBS,!and!then!received!one!of!the!following!treatments!in!glucose)free,!
bicarbonate)free!DMEM:!!
1. 500!nM!dexamethasone!
2. 100!nM!glucagon!with!1mM!sodium!pyruvate!
!

!
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3. 10!nM!insulin,!Wnt!(100!ng/mL)!
4. Wnt!and!dexamethasone!
5. Wnt!and!glucagon!with!1mM!sodium!pyruvate!
6. dexamethasone!and!insulin!
7. glucagon!and!insulin!

Media!was!sampled!at!1,!3,!5,!12,!and!24!hrs!after!treatment!was!initiated.!The!24!
hour!time!point!data!were!used!for!the!analyses!reported!here.!Cells!were!washed!
with!PBS!and!RNA!extracted!using!the!RNeasy!kit!(Qiagen,!Valencia,!CA).!
!
HepG2&Cell&culture.!!Cells!were!thawed!and!centrifuged!according!to!the!ATCC!
recommended!protocol.!They!were!then!treated!with!the!same!reagents!under!
identical!conditions!as!described!above!in!the!section!on!Primary!Hepatocyte!Cell!
Cultures.!!
!
INS51&Cell&Culture.!!This!experiment!was!performed!in!collaboration!with!Dr.!Richard!
Kibbey!(Yale!University;!New!Haven,!CT)!and!Rebecca!Pongratz!from!his!laboratory.!
INS)1&cells!were!maintained!as!monolayers!in!RPMI!1640!complete!medium!with!
11.1mM!D)glucose!supplemented!with!10%!(v/v)!fetal!bovine!serum,!antibiotics!
(10,000!units/ml!penicillin!and!10!mg/ml!streptomycin),!10mM!HEPES,!4mM!L)
glutamine,!1mM!sodium!pyruvate,!and!50mM!beta)mercaptoethanol.!For!
experiments,!cells!were!plated!into!6)well!plates!at!a!density!of!2.0!x105!cells!per!
well!and!cultured!at!37°C!until!80%!confluent.!Cells!were!then!randomly!assigned!to!

!
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three!conditions:!Wnt!pretreatment,!no!Wnt!pretreatment,!or!no!Wnt!treatment.!For!
pretreatment!Wnt!(100ng/mL)!was!added!the!night!prior!to!glucose!stimulation.!
Equivalent!amounts!of!PBS!were!added!to!the!non)pretreatment!cells!to!ensure!
equivalent!volumes!of!media.!On!the!day!of!treatment!cells!were!washed!with!PBS!
and!then!pre)incubated!in!basal!media!for!90!minutes.!Basal!media!was!glucose)free!
DMEM!containing!3.7g/L!NaHCO3,!4!mM!glutamine,!10!mM!HEPES,!2.5!mM!dextrose!
and!0.2%!96%!fatty!acid)free!bovine!serum!albumin.!Wnt!was!added!to!the!media!of!
cells!selected!for!Wnt!treatment.!Media!was!then!changed!to!basal!media!containing!
either!2.5mM!dextrose!±Wnt,!or!stimulation!media!containing!9mM!dextrose!±Wnt!
for!45!minutes.!Following!the!incubation,!media!fractions!were!collected!and!placed!
on!ice!until!analyzed!for!insulin!content.!The!remaining!media!was!aspirated,!cells!
were!washed!with!PBS!x2!and!then!1!ml!of!ice!cold!0.1%!Triton!X100!was!added.!
Cell!lysates!were!collected!and!assayed!for!protein.!!
!
INS51&insulin&analysis.!Insulin!concentration!in!the!conditioned!media!was!measured!
using!the!High!Range!Rat!Insulin!ELISA!kit!in!96)well!plates!(ALPCO!Diagnostics,!
Salem,!NH).!All!media!extracts!were!normalized!to!a!cell!protein!concentration!using!
a!Micro)BCA!Protein!Assay!Kit!(Thermo!Scientific;!Waltham,!MA)!and!the!
manufacturer’s!recommended!protocol.!!
!
Human&islet&perfusion.!This!experiment!was!also!performed!in!collaboration!with!Dr.!
Kibbey!and!Ms.!Pongratz.!Human!islets!were!obtained!from!the!University!of!Alberta!
Islet!Core,!Alberta!Diabetes!Institute,!Edmonton!(Pigeau!et!al.,!2009).!Islets!were!

!
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cultured!in!complete!CMRL!media!at!37°C!with!5%!CO2,!95%!air!until!the!time!of!
the!experiment.!Prior!to!perfusion,!approximately!160!islets!(40!islets/per!
replicate)!were!pretreated!with!Wnt!(75ng/mL)!for!19!hours.!Another!160!islets!
were!designated!as!the!control!(no!Wnt!pretreatment).!Islets!were!perfused!with!
DMEM!basal!media!containing!2.5mM!glucose!(D5030,!Sigma).!Forty!islets!per!
chamber!were!perifused!with!basal!media!for!45!minutes!to!equilibrate!the!islets!to!
the!column!and!instrument.!After!the!pre)incubation,!islets!were!perifused!with!the!
different!treatments!and!100ul!of!perifusate!collected!per!minute.!The!perifusion!
protocol!consisted!of!a!basal!period!of!2.5mM!glucose!for!20!min!in!which!Wnt!
(75ng/mL)!was!added!back!to!the!treatment!group!islets!after!10min!and!
maintained!for!the!duration!of!the!perifusion.!!The!basal!period!was!followed!by!a!
9mM!glucose!stimulation!for!45min.!The!glucose!concentration!was!then!reduced!to!
2.5!mM!glucose!for!15!min!followed!by!a!second!stimulation!with!30!mM!KCl!at!
2.5mM!glucose!(5min.)!to!evaluate!insulin!secretion!independent!of!glucose!
metabolism.!The!islets!were!then!allowed!to!recover!in!basal!media!for!5!min.!
Insulin!levels!in!the!perfustate!were!measured!with!an!ELISA!for!human!insulin!(80)
INSHU)E01,!ALPCO!Diagnostics,!Salem,!NH)!and!normalized!to!the!DNA!content!of!
the!cell!layer!(P7589,!Molecular!Probes).!
!
Quantitative&Real&Time&PCR.!Total!RNA!was!isolated!using!an!RNeasy!kit!(Qiagen,!
Valencia,!CA)!per!the!manufacturers!instructions.!cDNA!synthesis!was!carried!out!at!
43°!C!for!45!min!followed!by!denaturation!at!95°!C!for!five!minutes!using!a!cDNA!
synthesis!kit!(Stratagene,!La!Jolla,!CA).!Quantitative!Real!Time!PCR!(qPCR)!was!

!

!

!

17!

performed!with!TaqMan!PCR!reagent!kits!(Stratagene,!La!Jolla,!CA)!using!40!ng!of!
RNA!with!a!reaction!volume!of!20uL!using!the!Opticon!2!DNA!Engine!Continuous!
Fluorescence!Detection!System!(MJR,!Waltham,!MA).!Specific!primer/probe!sets!for!
target!genes!were!purchased!from!Applied!Biosystems)Life!Technologies!(Carlsbad,!
CA)!(see!Table!1).!All!qPCR!reactions!were!performed!in!duplicate,!and!cycling!
conditions!were!95°!C!for!20s!and!60°!C!for!1!min!for!39!cycles.!The!amplification!
signal!from!the!target!gene!was!normalized!to!a!beta5glucuronidase!signal!in!the!
same!reaction.!The!relative!expression!levels!were!determined!using!the!
comparative!CT!method!(also!known!as!the!2CT!method).!Data!are!presented!as!the!
relative!mRNA!levels.!
!
Statistical&Analyses.)We!estimated!we!could!recruit!11!subjects!from!the!affected!
kindreds!suitable!for!analysis!to!be!paired!with!22!matched!controls!in!a!2:1!ratio.!
Based!on!preliminary!control!data,!we!estimated!that!the!standard!deviation!(SD)!
for!HbA1c!would!be!0.22(%).!Since!we!did!not!know,!a&priori,!what!the!SD!would!be!
for!HbA1c!in!the!affected!individuals!we!conservatively!estimated!it!at!0.44(%).!
Using!these!estimates!for!SDs,!we!would!have!99%!power!to!see!a!difference!in!
HbA1c!values!of!0.5%!or!greater,!and!80%!power!to!see!a!difference!of!0.3%!or!
greater!(GraphPad!StatMate!2.0:!GraphPad!Software!Inc.,!La!Jolla,!CA).!
!
Statistical!differences!were!analyzed!using!the!unpaired!Student!t!test,!and!one)way!
ANOVA!where!appropriate!(GraphPad!Prism!version!6.00!for!Windows,!GraphPad!
Software;!La!Jolla!California!USA,!www.graphpad.com).!Data!presented!are!mean!
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±standard!error!of!the!mean!(SEM).!Differences!were!considered!statistically!
significant!when!p<0.05.!
)
RESULTS)
I)Human)Studies)
Baseline!characteristics!of!the!affected!subjects!and!the!age,!gender,!and!BMI)
matched!control!group!are!shown!in!Table!2.!Mean!BMI!of!these!groups!were!
27.4±1.8!and!27.6±1.1,!respectively.!
!
HbA1c&is&not&significantly&different&in&individuals&with&HBM&mutations&in&LRP5&&
The!parameters!of!glucose!metabolism!measured!in!the!study!subjects!are!
presented!in!Table!3.!Two!affected!subjects!were!known!diabetics!taking!insulin.!
These!subjects!and!their!four!matched!controls!were!excluded!from!analysis.!With!9!
affected!individuals!and!18!controls,!we!had!99%!power!to!see!a!1.0%!difference!
and!80%!power!to!see!a!0.6%!difference!in!HbA1c!values.!Changes!of!this!magnitude!
would!have!been!clinically!meaningful.!However,!we!did!not!observe!any!difference!
in!this!parameter.&There!were!no!statistically!significant!differences!between!
affected!and!control!populations!for!HbA1c!(p=0.06),!eAG!(p=0.06),!insulin!(p=0.82),!
HOMA)B!(p=0.34)!and!HOMA)IR!(p=0.66).!Mean!HbA1c!for!affected!and!control!
groups!were!5.8±0.3%!and!5.4±0.5%!respectively.!One!affected!subject!and!one!
control!subject!were!found!to!have!elevated!HbA1c!levels!in!the!diabetic!range!
(≥6.5)!when!tested!for!the!purposes!of!this!study.!HbA1c!values!are!depicted!in!
Figure!2.!&
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OGTT&results&were&not&significantly&different&in&individuals&with&HBM&LRP5&mutations&&
Three!subjects!with!the!HBM!LRP5!mutation!underwent!an!OGTT.!Blood!glucose!
(Fig.!3A),!insulin!(Fig.!3B)!and!c)peptide!(Fig.!3C)!levels!were!not!consistently!
different!from!the!control!group,!suggesting!that!there!is!no!difference!in!insulin!
production!as!well!as!in!insulin!sensitivity!in!these!three!individuals!when!
compared!to!a!large!control!group.!!
!
IMCL&and&liver&TG&is&not&significantly&different&in&individuals&with&HBM&mutations&in&
LRP5&
As!part!of!the!planned!investigation!into!the!role!of!LRP5!in!glucose!metabolism,!we!
also!measured!intramyocyte!lipid!as!an!index!of!insulin!sensitivity.!In!particular,!
there!is!a!substantial!literature!on!assessing!intramyocellular!lipid!(IMCL)!content!
as!a!biomarker!of!insulin!sensitivity:!Magnetic!resonance!spectroscopy!(MRS)!
studies!in!diabetic!and!non)diabetic!patients!have!shown!that!insulin!resistance!can!
be!attributed!to!post)receptor!defects!in!insulin!signaling,!for!example,!reduced!
Glut)4!transporter!activity!caused!by!metabolites!of!intracellular!lipids!(Morino,!
Petersen,!&!Shulman,!2006;!Petersen!et!al.,!2007).!!Studies!in!a!healthy,!lean!elderly!
individuals,!lean!and!obese!adolescents,!and!lean,!insulin!resistant!offspring!of!
patients!with!type!2!diabetes!(Petersen!et!al.,!2003;!Petersen,!Dufour,!Befroy,!Garcia,!
&!Shulman,!2004;!Sinha!et!al.,!2002),!all!support!the!conclusion!that!insulin!
resistance!results!from!the!intracellular!accumulation!of!fatty)acyl!CoAs,!and!
diacylglycerol!in!skeletal!myocytes!and!hepatocytes.!These!adverse!effects!can!be!
attenuated!with!weight!loss!(Petersen!et!al.,!2005;!Petersen!et!al.,!2012;!Rabol!et!al.,!

!
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2011).!!
!
Two!of!the!LRP5!affected!subjects!underwent!MRS!of!their!skeletal!muscle!and!liver!
(Table!4).!The!Insulin!Sensitivity!Index!(ISI)!was!predictably!higher!in!Subject!B!who!
had!a!lower!BMI,!lower!percent!body!fat,!and!higher!activity!level!(not!shown)!than!
Subject!A.!The!ISI!of!both!subjects!compared!to!the!control!groups!varies!predictably!
with!BMI!and!body!fat!percentage,!with!Subject!A!having!a!lower!percent!body!fat!
and!higher!ISI!compared!with!controls,!and!Subject!B!having!a!higher!BMI!and!lower!
ISI!compared!with!controls.!The!IMCL!in!both!subjects!was!not!significantly!different!
compared!to!the!control!group.!There!was!also!no!consistent!trend!in!liver!TG!
towards!higher!or!lower!percentage!lipids!compared!with!controls.!!
!
LDL&cholesterol&levels&are&lower&in&affected&study&subjects&
Lipid!profiles!for!the!affected!individuals!are!presented!in!Table!5.!Three!affected!
and!two!control!subjects!were!known!to!have!hypercholesterolemia!and!were!
taking!cholesterol)controlling!medications!at!the!time!of!study.!These!subjects,!and!
their!matched!controls,!were!excluded!from!the!analysis.!!
!
There!were!no!significant!differences!in!total!cholesterol,!TGs,!and!HDL,!between!
control!and!affected!subjects!(Figs.!4A)C).!However!as!shown!in!Figure!4D,!LDL!
levels!were!significantly!lower!in!affected!subjects!(p=0.04).!
!
!
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II)In#vitro)studies)
Tissue&survey&
As!an!initial!step!to!explore!the!role!of!Wnt!signaling!in!glucose!metabolism,!we!
surveyed!the!expression!of!LRP5!in!several!tissues!involved!in!fuel!metabolism.!
LRP5!expression!was!highest!in!liver,!and!lowest!in!bone!(Fig.!5).&These!data!largely!
agree!with!previously!published!tissue!expression!surveys!of!LRP5!(Hey!et!al.,!
1998).&
!
Testing&the&hypothesis&that&Wnt&suppresses&gluconeogenesis&by&inhibiting&PEPCK5C&
HBM!mutations!in!LRP5!are!posited!to!exert!their!effect!on!the!skeleton!by!causing!a!
functional!increase!in!Wnt!signaling.!This!is!not!due!to!ligand)independent!receptor!
signaling,!but!rather!due!to!a!resistance!of!these!mutant!receptors!to!endogenous!
inhibitors!such!as!DKK1.!Thus,!in!vivo,!these!mutant!receptors!transmit!a!greater!
signal!in!the!presence!of!endogenous!inhibitors!than!the!wild!type!receptor.!From!a!
functional!standpoint,!therefore,!these!mutations!constitute!gain)of)function!in!Wnt!
signaling.!We!therefore!sought!to!determine!the!effect!of!Wnt!signaling!on!glucose!
metabolism!by!testing!two!hypotheses.!!
!
The!first!was!that!Wnt!signaling!would!suppress!gluconeogenesis!by!inhibiting!one!
of!the!key!enzymes!in!the!gluconeogenic!pathway,!the!cytosolic!form!of!
phosphoenolpyruvate!carboxykinase!(PEPCK)C).!PEPCK)C!catalyzes!the!first!
committed!step!of!gluconeogenesis,!specifically!the!conversion!of!oxaloacetate+GTP!
–>!phosphoenolypyruvate!+GDP+C02.!It!is!not!regulated!post)translationally!or!

!
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allosterically!but!entirely!transcriptionally!such!that!enzyme!activity!is!directly!
proportional!to!the!level!of!transcript!expressed!in!the!liver.!(Chakravarty,!Cassuto,!
Reshef,!&!Hanson,!2005).!Previous!work!in!primary!hepatocytes,!hepatoma!cell!
lines,!and!animal!models!has!explored!the!effect!of!canonical!Wnt!signaling!on!
PEPCK)C!and!modulation!of!the!gluconeogenic!response!(Hall,!Wang,!George,!Koch,!
&!Granner,!2007;!Liu!et!al.,!2011).!While!the!PEPCK!promoter!has!no!known!
canonical!Wnt)binding!motifs,!PEPCK)C!is!inhibited!by!glucagon!synthase!kinase!3!
(GSK3)!a!downstream!target!for!canonical!Wnt!signaling.!Activation!of!Wnt!signaling!
suppresses!GSK3!activity!(Frame!&!Cohen,!2001).!Therefore!we!hypothesized!that!
Wnt!signaling!would!suppress!gluconeogenesis,!by!inhibiting!PEPCK)C!expression.!!
!
Wnt&does&not&effect&PEPCK5C&expression&in&primary&hepatocytes&
As!depicted!in!Figures!6A)C,!and!as!expected,!PEPCK!expression!in!primary!
hepatocytes!was!suppressed!by!insulin,!and!induced!by!dexamethasone!and!
glucagon.!PEPCK!induction!by!glucagon!was!blunted!by!insulin.!These!are!all!known!
effects!of!insulin,!dexamethasone!and!glucagon!and!confirm!that!our!in&vitro!assay!is!
sensitive!enough!to!detect!changes!induced!by!hormones!and!cytokines.!However,!
the!addition!of!Wnt!did!not!have!a!significant!suppressive!effect!on!PEPCK)C!
expression!as!compared!to!the!control!(Fig.!7A)!nor!did!it!blunt!the!effect!of!
glucagon!(Fig.!7C).!Unexpectedly,!Wnt!seemed!to!enhance!the!effect!of!
dexamethasone!though!the!change!was!not!statistically!significant!(Fig.!7B).!These!
results!were!confirmed!in!experiments!under!the!same!conditions!using!cells!from!
the!HepG2!cell!line.!

!

!

!

23!

Testing&the&hypothesis&that&Wnt&augments&glucose5stimulated&insulin&secretion&in&
pancreatic&islets&
The!effect!of!Wnt!on!insulin!release!from!pancreatic!islet!beta5cells!was!also!
explored!as!an!alternative!mechanism!by!which!Wnt!signaling!could!affect!glucose!
metabolism.!As!noted!earlier,!Wnt!fails!to!stimulate!insulin!secretion!from!islets!
isolated!from!LPR5!knock!out!mice;!conversely,!exposure!of!wild!type!islets!to!Wnt!
stimulated!glucose)induced!insulin!secretion!(Fujino!et!al.,!2003).!!
!
We!initially!undertook!studies!using!the!INS)1!832/23!cell!line!since!these!cells!have!
important!similarities!to!pancreatic!beta)cells!including!those!related!to!insulin!
secretion!(Cline,!Lepine,!Papas,!Kibbey,!&!Shulman,!2004;!Hohmeier!et!al.,!2000;!Lu!
et!al.,!2002;!Pongratz,!Kibbey,!Shulman,!&!Cline,!2007).!Therefore!we!expected!that!
the!results!in!these!cells!would!likely!mirror!those!in!primary!human!islets.!!
!
Wnt&does&not&augment&glucose5stimulated&insulin&secretion&in&INS51&cells&
9.0!mM!glucose!stimulated!insulin!secretion!in!INS)1!cell!two)fold!compared!to!the!
secretory!rate!under!basal!conditions!(2.5mM!Glucose).!Adding!Wnt!to!either!basal!
or!to!stimulatory!glucose!concentrations!had!no!statistically!significant!effect!on!
insulin!secretion!(Fig.8).!
!
Given!prior!reports!that!Wnt!is!active!in!pancreatic!beta)cells!we!next!sought!to!
confirm!LRP5!expression!in!the!INS)1!832/23!cells.!For!these!studies!the!level!of!
LRP5!transcript!expression!in!the!INS)1!832/23!cells!was!compared!to!that!in!

!
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primary!rat!islets.!LRP5!expression!is!significantly!lower!in!the!INS)1!832/23!cells!
when!compared!to!the!primary!cells!(Fig.!9).!This!suggests!that!Wnt!does!not!affect!
insulin!secretion!in!INS)1!832/23!cells!perhaps!in!part!because!the!level!of!receptor!
expression!is!too!low.!&
!
Wnt&does&not&augment&glucose5stimulated&insulin&secretion&in&primary&human&islets&
In!view!of!the!finding!that!LRP5!was!only!expressed!at!a!low!level!in!INS)1!832/23!
cells,!we!next!examined!the!effect!of!Wnt!on!insulin!section!in!primary!human!islets.!
Human!islets!are!known!to!have!robust!expression!of!LRP5!(Hey!et!al.,!1998).!That!
notwithstanding,!glucose)induced!insulin!secretion!in!primary!human!islets!was!not!
affected!by!Wnt!(Fig.!10).!While!these!data!are!consistent!with!our!finding!in!the!
INS)1!cells,!they!are!at!variance!with!prior!studies!using!murine!islets!in!which!Wnt!
treatment!led!to!a!doubling!of!glucose)induced!insulin!secretion!(Fujino!et!al.,!2003).!
!
DISCUSSION)
The!prevalence!and!reach!of!diabetes!across!generations!and!populations!is!well!
known.!Over!eight!percent!of!the!United!States!population!has!diabetes.!In!
particular,!there!is!an!increased!incidence!among!adolescent!and!non)white!
populations!(http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf).!Hospital!and!
health!systems!face!soaring!direct!medical!costs,!which!topped!$176!billion!in!2012.!
The!average!annual!cost!of!caring!for!a!diabetic!is!2.3!times!higher!than!a!non)
diabetic,!multiplying!the!cost!of!the!disease!across!hospitalizations!and!outpatient!
visits!("Economic!costs!of!diabetes!in!the!U.S.!in!2012,"!2013).!Notably,!these!
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estimates!do!not!account!for!the!additional,!significant!cost!of!reduced!productivity!
and!caregiver!burden.!
!
Wnt!signaling!through!LRP5!represents!a!newly!appreciated!metabolic!pathway!that!
might!be!a!target!for!drug!discovery!in!type!2!diabetes.!In!preadipocytes!Wnt!and!
insulin!signaling!have!been!shown!to!interact!with!LRP5!exerting!a!positive!effect!on!
insulin!signaling!(Palsgaard!et!al.,!2012).!Studies!in!rodents!support!the!conclusion!
that!LRP5!mediates!glucose!and!lipid!metabolism!(Fujino!et!al.,!2003;!Magoori!et!al.,!
2003).!However,!data!from!human!studies!in!LBM)causing!mutations!populations!
has!not!been!as!consistent,!with!some!studies!suggesting!that!these!individuals!have!
impaired!glucose!metabolism!and!others!failing!to!find!a!similar!trend!(Saarinen!et!
al.,!2010;!Zenibayashi!et!al.,!2008).!!
!
In!view!of!these!conflicting!data!and!because!a!variety!of!methodologies!have!been!
used!to! measure!glucose!and!lipid!metabolism!we!revisited!the!relationships!in!a!
human!population!that!has!not!yet!been!studied:!Those!with!HBM)causing)mutant!
LRP5!receptors.!!
!
Our!data!show!that!compared!to!matched!controls,!individuals!with!HBM)causing!
LRP5!mutations!did!not!demonstrate!improved!glucose!homeostasis.!HbA1c,!a!
common!clinical!test!for!diagnosis!and!clinical!monitoring!of!diabetes,!was!not!
significantly!different!between!control!and!affected!populations.!Similarly,!there!was!
no!difference!in!eAG,!insulin!levels,!Homa)B,!and!Homa)IR!scores.!As!noted,!our!
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study!included!members!of!multiple!kindreds,!encompassing!two!different!HBM)
causing!mutations!in!LRP5.!While!the!study!was!sufficiently!powered!to!detect!a!
difference!in!HbA1c!between!the!two!study!groups,!it!was!not!possible!to!do!a!
meaningful!sub)analysis!of!the!small!number!of!individuals!with!the!N198S!
mutation!to!determine!if!their!response!differed!from!that!in!the!individuals!with!
the!G171V!mutations.!However,!a!sub)analysis!of!G171V!mutation!kindred!members!
alone!also!demonstrated!no!significant!difference!from!the!control!group!(p=0.07)!
(data!not!shown).!In!other!studies!in!these!kindreds!it!has!been!suggested!that!the!in!
vivo!actions!of!these!two!mutation!differed!(Lee!et!al.,!2013).!!
!!
A!smaller!sample!of!affected!LRP5!subjects!underwent!an!OGTT!and!MRS!of!liver!
and!skeletal!muscle.!In!agreement!with!the!data!in!the!larger!study!group,!blood!
glucose,!insulin!levels,!and!c)peptide!levels!were!no!different!in!these!three!
individuals!compared!to!controls.!The!ISI!varied!appropriately!with!BMI,!percent!
body!fat!and!activity!level,!and!there!was!no!trend!to!indicate!improved!insulin!
sensitivity!in!the!two!affected!individuals!who!participated!in!these!analyses.!
Previous!studies!have!found!a!strong!relationship!between!IMCL!content!and!
muscle!insulin!resistance,!suggesting!that!intracellular!lipid!metabolites!might!be!a!
causal!factor!in!its!pathogenesis.!MRS!measures!of!TG!in!muscle!and!liver!are!useful!
proxies!for!assessing!specific!fatty!acid!content!(i.e.!diacylglycerols)!that!could!
otherwise!only!be!evaluated!with!invasive!techniques!such!as!muscle!biopsy.!We!
hypothesized!that!one!mechanism!by!which!LRP5!affected!individuals!could!have!
improved!glucose!metabolism!was!through!improved!insulin!sensitivity!resulting!
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from!reduced!IMCL!content.!Given!our!small!sample!size,!we!would!have!needed!to!
see!a!very!robust!difference!between!the!findings!in!the!two!study!subjects!and!the!
entire!control!group.!However,!insulin!sensitivity!in!these!two!study!subjects!was!no!
different!from!that!of!the!control!subjects.!!It!is!worth!recalling!that!two!affected!
subjects!were!taking!insulin!and!were!excluded!from!these!analyses.!A!third!affected!
subject!was!found!to!have!a!serum!HbA1c!in!the!diabetic!range.!These!observations!
support!the!findings!that!HBM)causing!mutations!do!not!impact!glucose!
homeostasis.!Consistent!with!that,!our!data!also!indicate!that!HBM)causing!LRP5!
mutations!do!not!improve!insulin!sensitivity!or!insulin!production.!If!LRP5!plays!a!
role!in!glucose!homeostasis,!then!this!study!suggests!that!its!impact!is!minimal!in!
comparison!to!more!dominant!factors!thus!keeping!us!from!observing!it!in!a!small!
population.!
!
In!addition!to!effects!on!glucose!homeostasis,!animal!studies!also!point!to!a!role!for!
LRP5!in!lipid!homeostasis.!LRP5)/)!mice!fed!high!fat!diets!had!elevated!cholesterol,!
and!impaired!plasma!clearance!of!diet)derived!triglycerides!implying!a!possible!
ApoE)independent!role!for!LRP5!in!triglyceride!hydrolysis!(Magoori!et!al.,!2003).!
However,!studies!in!human!LBM)causing!mutation!populations,!have!not!found!
differences!in!lipid!levels.!Of!note,!these!studies!were!not!control)matched,!and!one!
study!included!multiple!subjects!on!lipid!lowering!drugs.!(Saarinen!et!al.,!2010;!
Zenibayashi!et!al.,!2008).!!
!
Our!analysis!excluded!individuals!on!lipid!lowering!drugs!and!controlled!for!gender,!
age,!and!BMI.!Total!cholesterol,!triglycerides!and!HDL!were!not!different!between!
!
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affected!and!controls!populations.!However,!LDL!was!significantly!lower!in!the!
affected!subjects.!This!finding!is!particularly!interesting!as!the!LRP5!receptor!is!
known!to!bind!ApoE)containing!lipoproteins!in&vitro&(Kim!et!al.,!1998).!!
!
LRP5!is!known!to!be!highly!expressed!in!the!liver!and!in!hepatocytes!(Hey!et!al.,!
1998;!Kim!et!al.,!1998).!We!confirmed!this!in!the!current!study.!We!hypothesized!
that!the!addition!of!Wnt!would!inhibit!PEPCK)C,!a!rate)limiting!step!in!the!
gluconeogenic!pathway.!Since!accelerated!gluconeogenesis!plays!an!important!role!
in!type!2!diabetes,!this!hypothesis!had!considerable!clinical!relevance.!However!our!
in&vitro&studies!consistently!showed!no!effect!Wnt!on!PEPCK)C!in!primary!
hepatocytes.!Neither!the!induction!of!PEPCK!by!dexamethasone!or!glucagon!or!the!
suppression!by!insulin!was!affected!by!Wnt.!It!remains!possible!that!Wnt!signaling!
through!LRP5!has!targets!genes!other!than!PEPCK!to!modulate!gluconeogenesis,!
that!were!not!considered!in!the!current!study.!!
!
We!also!examined!the!effect!of!Wnt!treatment!in!INS)1!cells!and!human!islets!to!
assess!the!impact!this!has!on!insulin!secretion.!Rat!INS)1!cells,!considered!a!valid!
system!to!study!insulin!secretion!dynamics!(Hohmeier!et!al.,!2000),!responded!
appropriately!to!glucose!stimulation!with!a!robust!increase!in!insulin!secretion.!
However,!they!did!not!further!increase!insulin!production!in!response!to!Wnt!
treatment.!Since!these!cells!had!low!levels!of!LRP5!compared!with!primary!rat!islets,!
these!studies!were!extended!to!human!islets.!Wnt!treatment!for!16!hours!did!not!
change!human!insulin!production!under!basal!or!glucose)stimulated!culture!
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conditions.!These!findings!are!at!odds!with!the!finding!that!Wnt!increased!glucose)
induced!insulin!secretion!in!murine!islets!(Fujino!et!al.,!2003).!The!reason!for!these!
divergent!findings!is!not!clear.!One!obvious!possibility!is!that!murine!and!human!
islets!respond!differently!to!Wnt.!Why!then!does!murine!bone!apparently!faithfully!
recapitulate!the!effects!of!Wnt!on!the!human!skeleton?!This!may!be!because!the!
macroarchitecture!of!bone!as!well!as!the!interactions!of!bone!cells!are!very!similar!
in!mouse!and!man.!In!contrast,!the!architecture!of!the!murine!islet!as!well!as!its!
cellular!composition!is!different!from!the!human!islet!(Steiner!et!al.,!2010),!and!so!
may!be!the!biological!mechanism!involved!in!the!development!and!maintenance!of!
these!tissues.!!!
!
Conclusion&
Studies!of!LBM)causing!mutations!in!LRP5!in!both!experimental!models!and!in!
humans!with!OPPG!suggest!that!loss!of!function!in!this!receptor!is!associated!with!
impaired!glucose!tolerance.!However!these!studies!are!limited!by!the!lack!of!control!
groups!and!small!numbers!of!subjects!studied.!Our!study,!the!first!in!humans!with!
HBM)causing!mutations!in!LRP5,!included!a!carefully!matched!control!group!and!a!
larger!number!of!affected!individuals.!These!findings!provide!strong!evidence!for!a!
limited!role!of!LRP5!in!glucose!metabolism!as!we!could!not!demonstrate!an!
interaction!between!the!two.!!
!
The!HBM)causing!mutations!studied!in!our!kindreds!are!not!tissue)specific!in!their!
actions!(as!demonstrated!by!our!expression!survey),!and!should!change!Wnt!
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signaling!anywhere!that!Wnt!acts.!Our!study!population!included!two!HBM)causing!
mutations,!each!with!extreme!skeletal!phenotypes.!Given!the!robust!phenotype!in!
bone,!we!anticipated!a!considerable!phenotype!in!glucose!homeostasis.!Although!
the!sample!size!for!the!OGTT!and!MRS!sub)analyses!were!too!small!to!demonstrate!
statistical!significance,!we!could!identify!no!trend!toward!increased!insulin!
sensitivity!or!altered!insulin!production.!In!fact,!three!of!the!kindred!members!
screened!for!inclusion!in!this!study!had!diabetes!and/or!insulin!resistance.!These!
results!are!in!direct!contradiction!to!the!findings!in!previously!reported!animal!
models,!underscoring!the!potential!limitations!in!extending!some!findings!in!mice!to!
humans.!
!
While!our!findings!do!not!directly!evaluate!the!role!of!loss!of!function!mutations!in!
LRP5!on!glucose!metabolism,!they!do!make!LRP5!a!less!attractive!target!for!drug!
discovery!in!diabetes.!However,!it!does!appear!that!there!is!an!effect!on!LDL!
metabolism,!a!major!risk!factor!for!coronary!artery!disease.!To!detect!a!statistically!
significant!effect!on!LDL!even!with!our!small!sample,!certainly!suggests!that!the!
molecular!mechanism!underpinning!this!effect!warrants!further!study.!!
!
In!summary,!our!data!does!not!support!the!hypothesis!that!LRP5!improves!glucose!
metabolism!in!individuals!with!HBM)causing!LRP5!mutations.!The!data!suggest!that!
there!may!be!a!specific,!beneficial!effect!of!LRP5!on!LDL!cholesterol.!Additional!
studies!should!focus!on!clarifying!the!cellular!and!molecular!mechanisms!by!which!
these!occur.!

!

!

!

31!

FIGURES)&)TABLES)
)
Figure)1A.)G171V)Kindred)Pedigree)of)Family)A)

!

!

Affected!kindred!members,!indicated!by!dark!symbols,!have!a!single!base!pair!
mutation!causing!a!glycine!to!valine!change!at!position!171!in!the!low!density!
lipoprotein!related!receptor!protein!5!(LRP5).!This!results!in!a!high!bone!mass!
(HBM)!phenotype.!
!
!
Figure)1B.)G171V)Kindred)Pedigree)of)Family)B)

!

!

Affected!kindred!members,!indicated!by!dark!symbols,!have!a!single!base!pair!
mutation!causing!a!glycine!to!valine!change!at!position!171!in!the!low!density!
lipoprotein!related!receptor!protein!5!(LRP5).!This!results!in!a!high!bone!mass!
(HBM)!phenotype.!
!
!

!
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!

Table)1.)TaqMan)assays)used)for)qPCR)reactions.)
Gene)Symbol)
Pck1!

NCBI)gene)reference)
NM_198780.3!

TaqMan)assay)ID)
Rn01529014!

Alp1!

NM_007431.2!

Rn01516028!

LRP5!

NM_001106321.2!

Rn01451428!

Actb!

NM_031144.2!

Rn00667869!

!

QPCR!was!used!to!analyze!PEPCK)C!mRNA!expression!in!experiments!using!RNA!
from!primary!hepatocytes!and!HepG2!cells.!LRP5!mRNA!expression!was!analyzed!in!
a!variety!of!rat!tissues,!INS)1!cells,!and!primary!rat!islets.!!
)
Table)2.)Baseline)characteristics)of)all)study)participants)
Variable)
)
Age!(years)!

Affected)
(n=11))
63±7!

Matched)Controls)
(n=22))
63±4!

p)value)

Male!(n,!%)!

9!(82%)!

18!(82%)!

n/a!

Female!(n,!%)!

2!(18%)!

4!(18%)!

n/a!

BMI!(kg/m2)!

27.4!±1.8!

27.6±1.1!

0.92!

0.96!

!

The!term!“affected”!refers!to!those!study!subjects!with!the!HBM)causing!LRP5!
mutations.!There!were!no!statistical!differences!in!age!and!BMI!between!the!two!
groups.!There!were!equivalent!numbers!of!males!and!females!enrolled!in!both!
groups.!This!table!demonstrates!that!the!control!group!was!appropriately!matched!
for!these!characteristics!to!the!affected!individuals.!Data!is!shown!as!mean±SEM.!
!
!
!
!
!
!
!
!
!
!
!
!
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Table)3.)Measurements)of)glucose)metabolism)in)affected)study)participants)
Pt#)

BMI)
(kg/m2))
22.3!

HbA1c)
(%))
6.4!

eAGA)

1*!

LRP5)
genotype)
g171v!

2!

g171v!

20.8!

5.6!

114!

8.0!

2.3!

56.5!

3!

g171v!

35.0!

8.2!

188.6!

14.9!

6.9!

42.7!

4!

g171v!

34.0!

5.2!

102.5!

17.8!

4.5!

162.2!

5!

g171v!

29.4!

5.6!

114!

10.6!

3.0!

74.8!

6!

g171v!

24.8!

5.4!

108.3!

9.9!

2.7!

78.7!

7!

g171v!

32.7!

5.9!

122.6!

24.4!

7.4!

147.4!

8!

g171v!

26.7!

5.5!

111.2!

5.8!

1.6!

43.3!

9*!

g171v!

34.7!

6.8!

148.5!

12.1!

4.4!

51.0!

10!

n198s!

21.2!

5.7!

116.9!

12.4!

3.6!

82.8!

11!

n198s!

20.1!

5.4!

108.3!

7.0!

1.9!

55.6!

3.6±0.6&

74.7±13.0&

Mean±SEM&

27.4±1.8&

137!

Insulin) HOMAB[
(uU/mL))
IR)
5.5!
1.9!

6.0±0.3& 124.7±7.6& 11.7±1.7&

HOMA[B)
26.8!

A!Estimated!average!glucose=!28.7xHbA1c)46.7!(Nathan!et!al.,!2008)!
B!Homeostatic!Model!Assessment!

*!Subject!takes!insulin!
!

This!table!summarizes!the!results!of!the!studies!of!glucose!metabolism!in!the!
affected!individuals.!Two!subjects!using!insulin!were!excluded!from!subsequent!
analysis.!!
)
)
)
)
)
)
)
)
)
)
)

!

!

!
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Figure)2.)HbA1c)results)in)study)participants)
)

!

!

HbA1c!values!are!not!significantly!different!between!LRP5!affected!individuals!and!
age,!gender,!and!BMI!matched!controls!(p=0.06).!Error!bars!represent!the!standard!
error!of!the!mean.!
!
)
Figure)3A.)Changes)in)blood)glucose)during)the)OGTT)in)three)study)
participants))
)

!
!
Three!affected!subjects!underwent!an!OGTT.!There!was!no!consistent!difference!in!
glucose!levels!in!these!three!individuals!compared!to!a!group!of!previously!studied!
age,!race,!BMI,!and!activity)matched!controls!(N=54).!The!testing!and!control!data!
were!generously!provided!by!Dr.!Kitt!Falk!Petersen.!
!
!
!
!
!
!

!

!
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!
Figure)3B.!Changes)in)insulin)levels)during)the)OGTT)in)three)study)
participants))
)
!

!
!
Three!affected!subjects!underwent!an!OGTT.!There!was!no!consistent!difference!in!
insulin!levels!in!these!three!individuals!compared!to!a!group!of!previously!studied!
age,!race,!BMI,!and!activity)matched!controls!(N=54).!The!testing!and!control!data!
were!kindly!provided!by!Dr.!Kitt!Falk!Petersen.!Subject!B!has!more!intramyocyte!
lipid!and!is!likely!somewhat!insulin!resistant!(see!Table!4).!
!
!
Figure)3C.)Changes)in)C[peptide)levels)during)the)OGTT)in)three)study)
participants)
)
!

!
!
Three!affected!subjects!underwent!an!OGTT.!There!was!no!consistent!difference!in!
c)peptide!levels!in!these!three!individuals!compared!to!a!group!of!previously!
studied!age,!race,!BMI,!and!activity)matched!controls!(N=54).!The!testing!and!
control!data!was!kindly!provided!by!Dr.!Kitt!Falk!Petersen.!
!
!
!
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!
Table)4.)Intramyocellular)lipid)and)hepatic)lipid)triglyceride)content)by)
1HMRS)
Subject!A!

BMI)
(kg/m2))
27.8!

Subject!B!

25.7!

19.4!

6.6!

1.7!

0.6!

Control!(n=54)!

23.8±0.4!

27.6±1.4!

4.7±0.2!

1.3±0.1!

1.5±0.3!

Subject)

Body)Fat)(%))

ISI)

IMCL)(%))

Liver)TG)(%))

25.3!

3.1!

1.4!

4.3!

&

Two!affected!subjects!underwent!1HMRS!of!skeletal!muscle!and!liver!for!lipid!
content.!Subjects!were!compared!to!a!control!group!(n=54)!matched!for!age,!race,!
BMI,!and!activity!level.!While!the!sample!is!too!small!for!statistical!analysis,!there!
was!no!trend!observed!in!the!data!towards!higher!or!lower!percent!lipid!content,!
which!has!been!shown!to!be!an!important!marker!of!insulin!resistance!(Petersen!et!
al.,!2007).!1HMRS!testing!was!generously!conducted!by!Dr.!Kitt!Falk!Petersen.!Data!
is!shown!as!mean±SEM.!
)
Table)5.)Lipid)levels)in)affected)individuals)
Pt#A,B)

BMI)
(kg/m2))

TG)
(mg/dL))

HDL)
(mg/dL))

LDL)
(mg/dL))

20.8!

Total)
Cholesterol)
(mg/dL))
115!

2!

49!

40!

65.2!

4!

34.0!

180!

112!

58!

99.6!

6!

24.8!

185!

66!

71!

100.8!

7!

32.7!

163!

104!

45!

97.2!

8!

26.7!

149!

44!

68!

72.2!

9!

34.7!

143!

140!

49!

66.0!

10!

21.2!

209!

132!

101!

81.6!

11!

20.1!

212!

96!

80!

112.8!

169.5±11.8&

92.9±12.9&

64.0±7.2&

86.9±6.4&

Mean±SEM& 26.9±2.2&

A!Genotypes!as!listed!in!Table!3.!
B!!Study!subjects!#1,!#3,!#5!were!excluded!for!reasons!described!in!text.!
C!LDL=TC)HDL)(TG/5)!(Friedewald!et!al.,!1972).!
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!

Figure)4A.)Comparison)of)total)blood)cholesterol)in)affected)and)control)
individuals)
)

!
Individuals!taking!lipid!lowering!drugs!were!excluded!from!the!analysis.!Total!
cholesterol!levels!were!not!significantly!different!(p=0.43).!Data!is!shown!as!
mean±SEM.!
)
)
Figure)4B.!Comparison)of)blood)triglyceride)levels)in)affected)and)control)
individuals)
!

!
!
Individuals!taking!lipid!lowering!drugs!were!excluded!from!the!analysis.!
Triglyceride!levels!were!not!significantly!different!(p=0.56).!Data!is!shown!as!
mean±SEM.!
)
)
)

!

!
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Figure)4C.!Comparison)of)high)density)lipoprotein)(HDL))level)in)affected)and)
control)individuals)
!

!
!
Individuals!taking!lipid!lowering!drugs!were!excluded!from!the!analysis..!HDL!levels!
were!not!significantly!different!(p=0.32).!Data!is!shown!as!mean±SEM.!
)
)
Figure)4D.)Comparison)of)low)density)lipoprotein)(LDL))levels)in)affected)and)
control)individuals)
)

!
!
Individuals!taking!lipid!lowering!drugs!were!excluded!from!the!analysis.!LDL!levels!
were!significantly!lower!in!affected!individuals!(p=0.04).!Data!is!shown!as!
mean±SEM.!
!
!
!
!
!
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Figure)5.)Relative)expression)of)LRP5)in)rat)tissues)
)

!
!
LRP5!expression!was!highest!in!the!liver,!and!lowest!in!bone.!Transcript!expression!
is!defined!as!fold!change!in!comparison!to!liver.!
!
!
Figure)6A.)Regulation)of)PEPCK[C)expression)in)primary)rat)hepatocytes)by)
insulin)
)

!
)
Phosphoenolpyruvate!carboxykinase!(cytosolic!form)!(PEPCK)C)!expression!in!
primary!rat!hepatocytes!was!measured!in!the!presence!of!known!inducers!and!
inhibitors!to!confirm!the!sensitivity!of!our!in&vitro!assay.!Insulin!predictably!
suppressed!PEPCK)C!expression!compared!to!the!control!(p=0.02).!Data!is!shown!as!
mean±SEM.!
!
!
!
!

!

!
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Figure)6B.)Regulation)of)PEPCK[C)expression)in)primary)rat)hepatocytes)by)
dexamethasone))
!

!
!
PEPCK)C!expression!in!primary!rat!hepatocytes!was!measured!in!the!presence!of!
known!inducers!and!inhibitors!to!confirm!the!sensitivity!of!our!in&vitro!assay.!
Dexamethasone!predictably!induced!PEPCK)C!expression!compared!to!the!control!
(p=0.05).!Data!is!shown!as!mean±SEM.!
)
)
Figure)6C.)Regulation)of)PEPCK[C)expression)in)primary)rat)hepatocytes)by)
glucagon,)insulin)and)dexamethasone)
!

!
!
PEPCK)C!expression!in!primary!rat!hepatocytes!was!measured!in!the!presence!of!
known!inducers!and!inhibitors!to!confirm!the!sensitivity!of!our!in&vitro!assay.!
Glucagon!predictably!induced!PEPCK)C!expression!compared!to!the!control.!This!
experiment!confirmed!the!induction!of!PEPCK)C!by!dexamethasone,!and!its!
!

!

!
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suppression!by!insulin!relative!to!control.!The!effect!of!glucagon!was!blunted!by!
insulin!(p=0.01).!Data!analyzed!using!one)way!ANOVA.!Data!is!shown!as!mean±SEM.!
!
!
Figure)7A.)Effect)of)Wnt)on)PEPCK[C)expression)in)primary)rat)hepatocytes))
)

!
!
PEPCK)C!levels!were!measured!after!treatment!for!24!hours!with!100ng/ml!of!Wnt.!
Wnt!had!no!effect!on!PEPCK)C!transcript!expression!(p=0.42).!Data!is!shown!as!
mean±SEM.!
!
!
Figure)7B.))Effect)of)Wnt)and)Dexamethasone[induced)expression)of)PEPCK[C))
in)primary)rat)hepatocytes))
)

!
)
PEPCK)C!transcript!levels!were!measured!after!treatment!with!Wnt!or!Wnt!in!
combination!Dexamethasone.!Dexamethasone!alone!induced!PEPCK)C!expression.!
The!addition!of!Wnt!did!not!significantly!change!the!effect!of!dexamethasone!
(p=0.42).!Data!is!shown!as!mean±SEM.!
)
!

!

!
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Figure)7C.!Effect)of)Wnt)and)glucagon)on)PEPCK[C)expression)in)primary)rat)
hepatocytes))
)

!
!
PEPCK)C!levels!were!measured!in!after!treatment!with!Wnt!or!in!combination!with!
glucagon.!Glucagon!alone!induced!PEPCK)C!expression.!The!addition!of!Wnt!did!not!
significantly!alter!the!response!to!glucagon!(p=0.90).!Data!is!shown!as!mean±SEM.!
!
!
Figure)8.)The)effect)of)Wnt)on)glucose[induced)insulin)secretion)in)INS[1)cells))
)

!
!
INS)1!cells!were!treated!with!Wnt!in!the!presence!of!basal!(2.5mM)!and!stimulatory!
(9.0!mM)!levels!of!glucose)!High!extracellular!glucose!significantly!increased!insulin!
secretion.!However,!the!addition!of!Wnt!did!not!change!basal!or!glucose)stimulated!
insulin!secretion.!Data!is!shown!as!mean±SEM.!
!
!
!
!
!
!

!
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Figure)9.)LRP5)transcript)expression)in)INS[1)cells)and)primary)rat)islets.))
)

!
LRP5!transcript!expression!in!the!INS)1!cells!was!compared!to!that!in!primary!rat!
islets.!LRP5!expression!in!INS)1!cells!was!less!than!half!of!that!in!the!primary!rat!
islets.!!
!
!
Figure)10.)Effect)of)Wnt)on)glucose[induced)insulin)release)from)primary)
human)islets)
)

!
!
Human!islets!were!perifused!with!Wnt!and!exposed!to!basal!(2.5mM)!and!
stimulatory!(9.0mM)!concentrations!of!glucose.!Glucose)induced!insulin!secretion!
was!not!affected!by!Wnt!treatment.!
!
!
!
!
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